All News

The legislation would require that patients with cancer have access to oral oncology drugs within 72 hours of having the prescription submitted to the patient’s pharmacy benefits manager.

Patients who added dupilumab to standard of care saw a 65% reduction in the rate of severe asthma attacks over 1 year.

Pharmacists should counsel patients periodically to ensure correct usage for better disease and treatment management.

The researchers analyzed immunization records for more than 300,000 Texas children from birth to 24 months.

David Silverstein, JD, MS, a partner in Axinn’s Intellectual Property Practice Group and FDA practice groups, discusses the challenges posed by the White House’s support for the proposal to the WTO to waive IP protections for COVID-19 vaccines.

Incidence rates of early-onset colorectal cancer in the United States have increased from 8.6 to 13.1 per 100,000 between 1992 and 2013, with most of this increase attributable to early-onset cancers of the rectum.

Jay Lieberman, MD, a pediatric infectious disease specialist and the senior medical director of PRA Health Sciences, on the future of COVID-19 disease and vaccines for adolescents and children.

During a recent roundtable discussion, industry leaders shared frontline insights on the biggest drug diversion challenges.

Inhibiting Toll-like receptor 4 stopped it from accumulating cisplatin, thereby halting the hearing damage caused by the cancer treatment.

The researchers are hopeful this could eventually lead to the elimination of long-term antiretroviral treatment as a lifelong necessity for patients with HIV.

Selinexor in combination with bortezomib and dexamethasone is used for adult patients with multiple myeloma who have received at least 1 prior therapy.

most women reported 1 or more episodes of weight cycling, and each additional weight cycling episode was related to shorter sleep duration and poorer sleep quality.

Both strains of Influenza A for the northern hemisphere vaccines will be different from those included last season.

The goal of this year’s competition was to propose a technology-driven solution to address pandemics, mental health, or social determinants of health (SDOH).

New research results show that over the next decade COVID-19 may be more like the common cold.

As more companies enter this space, expect competition to further lower prices while improving quality.

A single pharmacy manager can be opportunistic enough to incorporate new technologies and build relationships that can serve to impact revenue reimbursement schema.

David Silverstein, JD, MS, a partner in Axinn’s Intellectual Property Practice Group and FDA practice groups, discusses the implications of the White House support for the proposal presented to the WTO to waive IP protections for COVID-19 vaccines.

The COVID-19 pandemic has had a massive impact on pharmacy students’ educations, according to a group of third-year students from the Washington State University College of Pharmacy and Pharmaceutical Sciences.

No cases of COVID-19 were observed in the vaccine group using the case definition from the adult phase 3 COVE study, compared to 4 cases in the placebo group.

Support groups and patient care clinics have been created to help patients who suffer from lasting effects of the virus.

Breast cancer patients with low or absent MLH1 or PMS2 gene expression may have even greater risks of death.

This discovery could enhance efforts to develop better treatments for breast, ovarian, and prostate cancer.

The basal subtype of ductal adenocarcinoma can be identified by the presence of the DeltaNp63 protein.

Program participants had 55% fewer hospitalizations, 45% fewer emergency department visits, and shorter hospital stays by 1 day in the 30 days after study entry.

The objective of the study was to determine whether atezolizumab could also be efficacious for patients with earlier-stage disease who may be at risk of disease recurrence following surgery